Fact checked by Nick Blackmer Some companies now offer multi-cancer early detection tests designed to screen for multiple ...

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ...

The test, which screens for DNA that is released when cancer cells die, is now one of multiple options for colorectal cancer screening. Guardant Health's Shield blood test for colorectal cancer ...

Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats ...

A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people. The results were presented at the 2025 American Society of Clinical ...

Please provide your email address to receive an email when new articles are posted on . Among all the CRC screening methods, CRC incidence and mortality rates were highest among those who received ...

The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...

Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

A second blood test shows promise for the detection of colon cancer, according to a new study. The first, called Shield, was approved by the Food and Drug Administration in July for people 45 and ...

A blood biomarker for Alzheimer's disease also indicates damage to the heart and kidneys, complicating early and clinical ...